Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Abbreviations::
-
Full name:
- 1B4M:
-
p-Isothiocyanatobenzyl)-6-methyl-diethylenetriamine pentaacetic acid
- AB:
-
Apical-to-basolateral
- BA:
-
Basolateral-to-apical
- BRI:
-
Biomolecular Research Institute
- CAT:
-
Chloramphenicol acetyl-transferase
- CT:
-
Computed topography
- Da:
-
Daltons
- DAB:
-
Diaminobutane
- DMPC:
-
1,2-Dimyristoyl-sn-glycero-3-phosphocholine
- DNA:
-
Deoxyribonucleic acid
- DTPA:
-
Diethylenetriaminepentaacetic acid
- EEA-1:
-
Early endosomal antigen 1
- FITC:
-
Fluorescein isothiocyanate
- G:
-
Generation
- Gd:
-
Gadolinium
- GI:
-
Gastrointestinal
- HSV-2:
-
Herpes simplex virus type 2
- ID/g:
-
Injected dose per gram
- IR:
-
Infra-red
- LAMP-1:
-
Lysosome-associated membrane protein 1
- LDH:
-
Lactate dehydrogenase
- MALDI-TOF:
-
Matrix-assisted laser desorption ionization time of flight
- MDCK:
-
Madin–Darby canine kidney
- MRI:
-
Magnetic resonance imaging
- MTT:
-
3-(4,5-Dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide
- NMR:
-
Nuclear magnetic resonance
- P app :
-
Apparent permeability
- PAGE:
-
Polyacrylamide gel electrophoresis
- PAMAM:
-
Poly(amidoamine)
- PEG:
-
Poly(ethylene glycol)
- PEI:
-
Poly(ethyleneimine)
- PEO:
-
Poly(ethylene oxide)
- P-gp:
-
P-glycoprotein
- PPI:
-
Poly(propyleneimine)
- PVA:
-
Poly(vinyl alcohol)
- SANS:
-
Small-angle neutron scattering
- SAXS:
-
Small-angle X-ray scattering
- SDS:
-
Sodium dodecyl sulfate
- TEER:
-
Transepithelial electrical resistance
- TEM:
-
Transmission electron microscopy
- TNF-α:
-
Tumor necrosis factor
References
Adamson, R. H., & Clough, G. (1992). Plasma proteins modify the endothelial cell glycocalyx of frog mesenteric microvessels. J Physiol, 445, 473–486.
Artursson, P. (1990). Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J Pharm Sci, 79(6), 476–482.
Aulenta, F., Drew, M. G., Foster, A., Hayes, W., Rannard, S., Thornthwaite. D. W., Worrall, D. R., Youngs, T. G. (2005). Synthesis and characterization of fluorescent poly (aromatic amide) dendrimers. J Org Chem, 70(1), 63–78.
Aungst, B. J. (2000). Intestinal permeation enhancers. J Pharm Sci, 89(4), 429–442.
Bayele, H. K., Ramaswamy, C., Wilderspin, A. F., Srai, K. S., Toth, I., & Florence, A. T. (2006). Protein transduction by lipidic peptide dendrimers. J Pharm Sci, 95(6), 1227–1237.
Behr, J. P. (1994). Gene transfer with synthetic cationic amphiphiles: Prospects for gene therapy. Bionconjug Chem, 5(5), 382–389.
Bielinska, A., Kukowska-Latallo, J. F., Johnson, J., Tomalia, D. A., & Baker, J. R., Jr. (1996). Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res, 24(11), 2176–2182.
Boas, U, Karlsson, A. J., de Waal, B. F., Meijer, E. W. (2001). Synthesis and properties of new thiourea-functionalized poly (propylene imine) dendrimers and their role as hosts for urea functionalized guests. J Org Chem, 66(6), 2136–2145.
Bourne, N. (2000). Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection. Antimicrob Agents Chemother, 44(9), 2471–2474.
Brauge, L., Magro, G., Caminade, A. M., & Majoral, J. P. (2001). First divergent strategy using two AB(2) unprotected monomers for the rapid synthesis of dendrimers. J Am Chem Soc, 123(27), 6698–6699.
Brothers II, H. M., Piehler, I. T., & Tomalia, D. A. (1998). Slab-gel and capillary electrophoretic characterization of polyamidoamine dendrimers. J Chromatogr A, 814(1–2), 233–246.
Caminade, A. M., Laurent, R., & Majoral, J. P. (2005). Characterization of dendrimers. Adv Drug Del Rev, 57(15), 2130–2146.
Chai, M., Niu, Y., Youngs, W. J., Rinaldi, P.L. (2001). Structure and conformation of DAB dendrimers in solution via multidimensional NMR techniques. J Am Chem Soc, 123(20), 4670–4678.
Chai, M., Pi, Z., Tessier, C., & Rinaldi, P. L. (1999). Preparation of carbosilane dendrimers and their characterization using 1H/13C/29Si triple resonance 3D NMR methods. J Am Chem Soc, 121(2), 273–279.
Chauhan, A. S., Sridevi, S., Chalasani, K. B., Jain, A. K., Jain, S. K., & Jain, N. K. (2003). Dendrimer-mediated transdermal delivery: Enhanced bioavailability of indomethacin. J Control Release, 90(3), 335–343.
Chen, H. T., Neerman, M. F., Parrish, A. R., & Simanek, E. E. (2004). Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery. J Am Chem Soc, 126, 10044–10048.
Choe, Y. H., Conover, C. D., Wu, D., Royzen, M., Gervacio, Y., & Borowski, V. (2002). Anticancer drug delivery systems: Multi-loaded N4-acyl poly(ethylene glycol) prodrugs of ara-C. II. Efficacy in ascites and solid tumors. J Control Release, 79(1–3), 55–70.
Choi, Y. S., Thomas, T., Kotlayr, A., Islam, M. T., & Baker, J. R. (2005). Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting. Chem Biol, 12(1), 35–43.
Cloninger, M. J. (2002). Biological applications of dendrimers. Curr Opin Chem Biol, 6(6), 742–748.
D'Emanuele, A., & Attwood, D. (2005). Dendrimer-drug interactions. Adv Drug Deliv Rev, 57(15), 2147–2162.
D'Emanuele, A., Jevprasesphant, R., Penny, J., & Attwood, D. (2004). The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability. J Control Release, 95(3), 447–453.
DeLong, R., Stephenson, K., Loftus, T., Fisher, M., Alahari, S., Nolting, A., & Juliano, R. L. (1997). Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery. J Pharm Sci, 86(6), 762–764.
Dufes, C., Keith, W. N., Bilsland, A., Proutski, I., Uchegbu, I. F., & Schatzlein, A. G. (2005a). Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors. Cancer Res, 65(18), 8079–8084.
Dufes, C., Uchegbu, I. F., & Schatzlein, A. G. (2005b). Dendrimers in gene delivery. Adv Drug Deliv Rev, 57(15), 2177–2202.
Duncan, R., & Izzo, L. (2005). Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev, 57(15), 2215–2237.
Duncan, R., & Spreafico, F. (1994). Polymer conjugates. Pharmacokinetic considerations for design and development. Clin Pharmacokinet, 27(4), 290–306.
Dunphy, I., Vinogradov, S. A., & Wilson, D. F. (2002). Oxyphor R2 and G2: Phosphors for measuring oxygen by oxygen-dependent quenching of phosphorescence. Anal Biochem, 310(2), 191–198.
El-Sayed, M., Ginski, M., Rhodes, C., & Ghandehari, H. (2002). Transepithelial transport of poly(amidoamine) dendrimers across Caco–2 cell monolayers. J Control Release, 81(3), 355–365.
El-Sayed, M., Ginski, M., Rhodes, C., & Ghandehari, H. (2003a). Influence of surface chemistry of poly (amidoamine) dendrimers on Caco-2 cell monolayers. J Bioactive Compat Poly, 18, 7–22.
El-Sayed, M., Rhodes, C. A., Ginski, M., & Ghandehari, H. (2003b). Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers. Int J Pharm, 265(1–2), 151–157.
El-Sayed, M., Kiani, M. F., Naimark, M. D., Hikal, A. H., & Ghandehari, H. (2001). Extravasation of poly(amidoamine) (PAMAM) dendrimers across microvascular network endothelium. Pharm Res, 18(1), 23–28.
Esfand, R., & Tomalia, D. A. (2001). Poly (amidoamine) (PAMAM) dendrimers: From biomimicry to drug delivery and biomedical applications. Drug Discov Today, 6(8), 427–436.
Felder, T., Schalley, C. A., Fakhrnabavi, H., & Lukin, O. (2005). A combined ESI- and MALDI-MS(/MS) study of peripherally persulfonylated dendrimers: False negative results by MALDI-MS and analysis of defects. Chemistry, 11(19), 5625–5636.
Fischer, D., Li, Y., Ahlemeyer, B., Krieglstein, J., & Kissel, T. (2003). In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysis. Biomaterials, 24(7), 1121–1131.
Florence, A. T. (1997). The oral absorption of micro- and nanoparticles: Neither exceptional nor unusual. Pharm Res, 14, 259–266.
Florence, A. T., Sakthivel, T., & Toth, I. (2000). Oral uptake and translocation of a polylysine dendrimer with a lipid surface. J Control Release, 65(1–2), 253–259.
Fu, Y., Nitecki, D. E., Maltby, D., Simon, G. H., Berejnoi, K., Raatschen, H. J., Yeh, B. M., Shames, D. M., & Brasch, R. C. (2006). Dendritic iodinated contrast agents with PEG-cores for CT imaging: Synthesis and preliminary characterization. Bioconjug Chem, 17(4), 1043–1056.
Grinstaff, M. W. (2002). Biodendrimers: New polymeric biomaterials for tissue engineering. Chemistry, 8(13), 2838–2846.
Haensler, J., & Szoka, F.C., Jr. (1993). Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bionconjug Chem, 4(5), 372–379.
Halford, B. (2005). Dendrimers branch out. Chem Eng News, 83, 30–36.
Hawker, C. J., & Frechet, J. M. J. (1990). Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules. J Am Chem Soc, 112(21), 7638–7647.
Hilgers, A. R., Conradi, R. A., & Burton, P. S. (1990). Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res, 7(9), 902–910.
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., Jain, & R. K. (1998). Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc Natl Acad Sci USA, 95(8), 4607–4612.
Hong, M. Y., Kim, Y. J., Lee, J. W., Kim, K., Lee, J. H., Yoo, J. S., Bae, S. H., Choi, B. S., & Kim, H. S. (2004a). Synthesis and characterization of tri(ethylene oxide)-attached poly(amidoamine) dendrimer layers on gold. J Colloid Interface Sci, 274(1), 41–48.
Hong, S., Leroueil, P. R., Janus, E. K., Peters, J. L., Kober, M. M., Islam, M. T., Orr, B. G. Baker, J. R., Jr., & Banaszak Holl, M. M. (2006). Interaction of polycationic polymers with supported lipid bilayers and cells: Nanoscale hole formation and enhanced membrane permeability. Bioconjug Chem, 17(3), 728–734.
Hong, S., Bielinska, A. U., Mecke, A., Keszler, B., Beals, J. L., Shi, X., Balogh, L., Orr, B. G., Baker, J. R., Jr., & Banaszak Holl, M. M (2004b). Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: Hole formation and the relation to transport. Bioconjug Chem, 15(4), 774–782.
Huang, Q. R., Dubin, P. L., Lal, J., Moorefield, C. N., & Newkome, G. R. (2005). Small-angle neutron scattering studies of charged carboxyl-terminated dendrimers in solutions. Langmuir, 21(7), 2737–2742.
Hughes, J. A., Aronsohn, A. I., Avrutskaya, A. V., & Juliano, R. L. (1996). Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides. Pharm Res, 13(3), 404–410.
Hummelen, J. C., Van Dongen, J. L. J., & Meijer, E. W. (1997). Electrospray mass spectrometry of poly(propylene imine) dendrimers – the issue of dendritic purity or polydispersity. Chem Eur J, 3(9), 1489–1493.
Ihre, H. R., Padilla De Jesus, O. L., Szoka, F. C., Jr., & Frechet, J. M. (2002). Polyester dendritic systems for drug delivery applications: Design, synthesis, and characterization. Bioconjug Chem, 13(3), 443–452.
Irvine, J. D., Takahashi, L., Lockhart, K., Cheong, J., Tolan, J. W., Selick, H. E., & Grove, J. R. (1999). MDCK (Madin-Darby Canine Kidney) cells: A tool for membrane permeability screening. J Pharm Sci, 88(1), 28–33.
Jackson, C. L., Chanzy, H. D., Booy, F. P., Drake, B. J., Tomalia, D. A., Bauer, B. J., & Amis, E. J. (1998). Visualization of dendrimer molecules by transmission electron microscopy (TEM): Staining methods and cryo-TEM of vitrified solutions. Macromolecules, 31(18), 6259–6265.
Jevprasesphant, R., Penny, J., Attwood, D., & D'Emanuele, A. (2004). Transport of dendrimer nanocarriers through epithelial cells via the transcellular route. J Control Release, 97(2), 259–267.
Jevprasesphant, R., Penny, J., Attwood, D., McKeown, N. B., & D'Emanuele, A. (2003a). Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity. Pharm Res, 20(10), 1543–1550.
Jevprasesphant, R., Penny, J., Jalal, R., Attwood, D., McKeown, N. B., & D'Emanuele, A. (2003b). The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharm, 252(1–2), 263–266.
Jiang, Y. H., Emau, P., Cairns, J. S., Flanary, L., Morton, W. R., McCarthy, T. D., & Tsai, C.C. (2005). SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6p in macaques. AIDS Res Hum Retroviruses, 21(3), 207–213.
Juliano, R. L. (2006). Intracellular delivery of oligonucleotide conjugates and dendrimer complexes. Ann NY Acad Sci, 1082, 18–26.
Kang, H., DeLong, R., Fisher, M. H., & Juliano, R. L. (2005). Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides. Pharm Res(12), 22, 2099–2106.
Kannan, S., Kolhe, P., Raykova, V., Glibatec, M., Kannan, R. M., Lieh-Lai, M., & Bassett, D. (2004). Dynamics of cellular entry and drug delivery by dendritic polymers into human lung epithelial carcinoma cells. J Biomater Sci Polym Ed, 15(3), 311–330.
Karoonuthaisiri, N., Titiyevskiy, K., & Thomas, J. L. (2003). Destabilization of fatty acid-containing liposomes by polyamidoamine dendrimers. Colloids Surf B Biointerfaces, 27(24), 365–375.
Khandare, J., Kolhe, P., Pillai, O., Kannan, S., Lieh-Lai, M., & Kannan, R. M. (2005). Synthesis, cellular transport, and activity of polyamidoamine dendrimer-methylprednisolone conjugates. Bioconjug Chem, 16(2), 330–337.
Kim, T. I., Seo, H. J., Choi, J. S., Jang, H. S., Baek, J. U., Kim, K., & Park, J. S. (2004). PAMAM-PEG-PAMAM: Novel triblock copolymer as a biocompatible and efficient gene delivery carrier. Biomacromolecules, 5(6), 2487–2492.
Kitchens, K. M., El-Sayed, M. E., & Ghandehari, H. (2005). Transepithelial and endothelial transport of poly (amidoamine) dendrimers. Adv Drug Deliv Rev, 57(15), 2163–2176.
Kitchens, K. M., Foraker, A. B., Kolhatkar, R. B., Swaan, P. W., & Ghandehari, H. (2007). Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells. Pharamaceutical Research, 24:2138–2145.
Kitchens, K. M., Kolhatkar, R. B., Swaan, P. W., Eddington, N. D., & Ghandehari, H. (2006). Transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers: Influence of size, charge and fluorescent labeling. Pharm Res, 23(12), 2818–2826.
Kobayashi, H., & Brechbiel, M. W. (2005). Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Deliv Rev, 57(15), 2271–2286.
Kobayashi, H., Kawamoto, S., Saga, T., Sato, N., Hiraga, A., Ishimori, T., Konishi, J., Togashi, K., & Brechbiel, M. W. (2001a). Positive effects of polyethylene glycol conjugation to generation-4 polyamidoamine dendrimers as macromolecular MR contrast agents. Magn Reson Med, 46(4), 781–788.
Kobayashi, H., Sato, N., Kawamoto, S., Saga, T., Hiraga, A., Haque, T. L., Ishimori, T., Konishi, J., Togashi, K., & Brechbiel, M. W. (2001b). Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer. Bioconjug Chem, 12(1), 100–107.
Kolhatkar, K., Kitchens, K. M., Swaan, P. & Ghandehari, H. (2007), Surface acetylation of poly(amidoamine) (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability, Bioconjugate Chemistry, 18, 2054–2060.
Kolhe, P., Khandare, J., Pillai, O., Kannan, S., Lieh-Lai, M., & Kannan, R. M. (2006). Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload. Biomaterials, 27(4), 660–669.
Kolhe, P., Khandare, J., Pillai, O., Kannan, S., Lieh-Lai, M., & Kannan, R. (2004). Hyperbranched polymer-drug conjugates with high drug payload for enhanced cellular delivery. Pharm Res, 21(12), 2185–2195.
Kolhe, P., Misra, E., Kannan, R. M., Kannan, S., & Lieh-Lai, M. (2003). Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int J Pharm, 259(1–2), 143–160.
Konda, S. D., Aref, M., Brechbiel, M., & Wiener, E. C. (2000). Development of a tumor-targeting MR contrast agent using the high-affinity folate receptor: Work in progress. Invest Radiol, 35(1), 50–57.
Langereis, S., de Lussanet, Q. G., van Genderen, M. H., Meijer, E. W., Beets-Tan, R. G., Griffioen, A. W., van Engelshoven, J. M., & Backes, W. H. (2006). Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging. NMR Biomed, 19(1), 133–141.
Launay, N., Caminade, A. M., & Majoral, J. P. (1995). Synthesis and reactivity of unusual phosphorus dendrimers. A useful divergent growth approach up to the seventh generation. J Am Chem Soc, 117(11), 3282–3283.
Lee, C. C., MacKay, J. A., Frechet, J. M., & Szoka, F. C. (2005). Designing dendrimers for biological applications. Nat Biotechnol, 23(12), 1517–1526.
Liu, M., & Frechet, J. M. (1999). Designing dendrimers for drug delivery. Pharm Sci Technol Today, 2(10), 393–401.
Liu, M., Kono, K., & Frechet, J. M. (2000). Water-soluble dendritic unimolecular micelles: Their potential as drug delivery agents. J Control Release, 65(1–2), 121–131.
Loup, C., Zanta, M. A., Caminade, A. M., Majoral, J. P., & Meunier, B. (1999). Preparation of water soluble cationic phosphorous containing dendrimers as DNA transfecting agents. Chem Eur J, 5(12), 3644–3650.
Luo, Y., & Prestwich, G. D. (2002). Cancer-targeted polymeric drugs. Curr Cancer Drug Targets, 2(3), 209–226.
Majoros, I. J., Myc, A., Thomas, T., Mehta, C. B., & Baker, J. R., Jr. (2006). PAMAM dendrimer-based multifunctional conjugate for cancer therapy: Synthesis, characterization, and functionality. Biomacromolecules, 7(2), 572–579.
Malik, N., Evagorou, E. G., & Duncan, R. (2000). Dendrimers: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release, 65(1–2), 133–148.
Malik, N., Evagorou, E. G., & Duncan, R. (1999). Dendrimer-platinate: A novel approach to cancer chemotherapy. Anticancer Drugs, 10(8), 767–776.
Maraval, V., Pyzowski, J., Caminade, A. M., & Majoral, J. P. (2003). “Lego” chemistry for the straightforward synthesis of dendrimers. J Org Chem, 68, 6043–6046.
Mecke, A., Majoros, I. J., Patri, A. K., Baker, J. R., Jr., Holl, M. M., & Orr, B. G. (2005). Lipid bilayer disruption by polycationic polymers: The roles of size and chemical functional group. Langmuir, 21(23), 10348–10354.
Mecke, A., Uppuluri, S., Sassanella, T. M., Lee, D. K., Ramamoorthy, A., Baker, J. R., Jr., Orr, B. G., & Banaszak Holl, M. M. (2004). Direct observation of lipid bilayer disruption by poly (amidoamine) dendrimers. Chem Phys Lipids, 132(1), 3–14.
Milhem, O. M., Myles, C., McKeown, N. B., Attwood, D., & D'Emanuele, A. (2000). Polyamidoamine starburst dendrimers as solubility enhancers. Int J Pharm, 197(1–2), 239–241.
Namazi, H., & Adeli, M. (2005). Dendrimers of citric acid and poly (ethylene glycol) as the new drug-delivery agents. Biomaterials, 26(10), 1175–1183.
Padilla De Jesus, O. L., Ihre, H. R., Gagne, L., Frechet, J. M., & Szoka, F. C., Jr. (2002). Polyester dendritic systems for drug delivery applications: In vitro and in vivo evaluation. Bioconjug Chem, 13(3), 453–461.
Patri, A. K., Kukowska-Latallo, J. F., & Baker, J. R., Jr. (2005). Targeted drug delivery with dendrimers: Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv Drug Deliv Rev, 57(15), 2203–2214.
Potschke, D., Ballauff, M., Lindner, P., Fischer, M., & Vogtle, F. (1999). Analysis of the structure of dendrimers in solution by small-angle neutron scattering including contrast variation. Macromolecules, 32(12), 4079–4087.
Prosa, T. J., Bauer, B. J., & Amis, E. J. (2001). From stars to spheres: A SAXS analysis of dilute dendrimer solutions. Macromolecules, 34(14), 4897–4906.
Quintana, A., Raczka, E., Piehler, L., Lee, I., Myc, A., Majoros, I., Patri, A. K., Thomas, T., Mule, J., & Baker, J. R., Jr. (2002). Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res, 19(9), 1310–1316.
Rajca, A. (1991). Synthesis of 1,3-connected polyarylmethanes. J Org Chem, 56(7), 2557–2563.
Rathgeber, S., Pakula, T., & Urban, V. (2004). Structure of star-burst dendrimers: A comparison between small angle x-ray scattering and computer simulation results. J Chem Phys, 121(8), 3840–3853.
Roberts, J. C., Bhalgat, M. K., & Zera, R. T. (1996). Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers. J Biomed Mater Res, 30(1), 53–65.
Rosenfeldt, S., Karpuk, E., Lehmann, M., Meier, H., Lindner, P., Harnau, L., & Ballauff, M. (2006). The solution structure of stilbenoid dendrimers: A small-angle scattering study. Chemphyschem, 7(10), 2097–2104.
Sadler, K., & Tam, J.P. (2002). Peptide dendrimers: Applications and synthesis. J Biotechnol, 90(3–4), 195–229.
Sakamoto, Y., Suzuki, T., Miura, A., Fujikawa, H., Tokito, S., & Taga, Y. (2000). Synthesis, characterization, and electron-transport property of perfluorinated phenylene dendrimers. J Am Chem Soc, 122(8), 1832–1833.
Sakthivel, T., Toth, I., & Florence, A. T. (1999). Distribution of a lipidic 2.5 nm diameter dendrimer carrier after oral administration. Int J Pharm, 183(1), 51–55.
Sanchez-Sancho, F., Perez-Inestrosa, E., Suau, R., Mayorga, C., Torres, M. J., & Blanca, M. (2002). Dendrimers as carrier protein mimetics for Ige antibody recognition. Synthesis and characterization of densely penicilloylated dendrimers. Bioconjug Chem, 13(3), 647–653.
Sedlakova, P., Svobodova, J., Miksik, I., & Tomas, H. (2006). Separation of poly(amidoamine) (PAMAM) dendrimer generations by dynamic coating capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci, 841(1–2), 135–139.
Shaunak, S., Thomas, S., Gianasi, E., Godwin, A., Jones, E., Teo, I., Mireskandari, K., Luthert, P., Duncan, R., Patterson, S., Khaw, P., & Brocchini, S. (2004). Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation. Nat Biotechnol, 22(8), 977–984.
Shi, X., Patri, A. K., Lesniak, W., Islam, M. T., Zhang, C., Baker, J. R., Jr., & Balogh, L. P. (2005). Analysis of poly(amidoamine)-succinamic acid dendrimers by slab-gel electrophoresis and capillary zone electrophoresis. Electrophoresis, 26(15), 2960–2967.
Singh, B., & Florence, A. T. (2005). Hydrophobic dendrimer-derived nanoparticles. Int J Pharm, 298(2), 348–353.
Svenson, S., & Tomalia, D. A. (2005). Dendrimers in biomedical applications – reflections on the field. Adv Drug Deliv Rev, 57(15), 2106–2129.
Tack, F., Bakker, A., Maes, S., Dekeyser, N., Bruining, M., Elissen-Roman, C., Janicot, M., Brewster, M., Janssen, H. M., de Waal, B. F., Fransen, P. M., Lou, X., & Meijer, E. W. (2006). Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes). J Drug Target, 14(2), 69–86.
Tajarobi, F., El-Sayed, M., Rege, B. D., Polli, J. E., & Ghandehari, H. (2001). Transport of poly amidoamine dendrimers across Madin-Darby canine kidney cells. Int J Pharm, 215(1–2), 263–267.
Takakura, Y., Mahato, R. I., & Hashida, M. (1998). Extravasation of macromolecules. Adv Drug Deliv Rev, 34(1), 93–108.
Tang, M. X., Redemann, C. T., & Szoka, F. C., Jr. (1996). In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem, 7(6), 703–714.
Tang, S., Martinez, L. J., Sharma, A., & Chai, M. (2006). Synthesis and characterization of water-soluble and photostable L-DOPA dendrimers. Org Lett, 8, 4421–4424.
Tansey, W., Ke, S., Cao, X. Y., Pasuelo, M. J., Wallace, S., & Li, C. (2004). Synthesis and characterization of branched poly(L-glutamic acid) as a biodegradable drug carrier. J Control Release, 94(1), 39–51.
Tomalia, D. A. (1993). StarburstTM/cascade dendrimers: Fundamental building bocks for new nanoscopic chemistry set. Aldrichimica Acta, 26(4), 91–101.
Tomalia, D. A. (2004). Birth of a new macromolecular architecture: Dendrimers as quantized building blocks for nanoscale synthetic organic chemistry. Aldrichimica Acta, 37(2), 39–57.
Tomalia, D. A., Naylor, A. M., & Goddard III, W. A. (1990). Starburst dendrimers. Molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem Int Ed Engl, 29(2), 138–175.
Tomlinson, R., Heller, J., Brocchini, S., & Duncan, R. (2003). Polyacetal-doxorubicin conjugates designed for pH-dependent degradation. Bioconjug Chem, 14(6), 1096–1106.
Torchilin, V. P. (2006). Multifunctional nanocarriers. Adv Drug Deliv Rev, 58(14), 1532–1555.
Trewhella, J., Gallagher, S. C., Krueger, J. K., & Zhao, J. (1998). Neutron and x-ray solution scattering provide insights into biomolecular structure and function. Sci Prog, 81(Pt 2), 101–122.
Turnbull, W. B., & Stoddart, J. F. (2002). Design and synthesis of glycodendrimers. J Biotechnol, 90(3–4), 231–255.
Velazquez, A. J., Carnahan, M. A., Kristinsson, J., Stinnett, S., Grinstaff, M. W., & Kim, T. (2004). New dendritic adhesives for sutureless ophthalmic surgical procedures: In vitro studies of corneal laceration repair. Arch Ophthalmol, 122(6), 867–870.
Wang, S. J., Brechbiel, M., & Wiener, E. C. (2003). Characteristics of a new MRI contrast agent prepared from polypropyleneimine dendrimers, generation 2. Invest Radiol, 38(10), 662–668.
Wiener, E. C., Brechbiel, M. W., Brothers, H., Magin, R. L., Gansow, O. A., Tomalia, D. A., & Laterbur, P. C. (1994). Dendrimer-based metal chelates: A new class of magnetic resonance imaging contrast agents. Magn Reson Med, 31(1), 1–8.
Wignall, G. D., & Melnichenko, Y. B. (2005). Recent applications of small-angle neutron scattering in strongly interacting soft condensed matter. Rep Prog Phys, 68(8), 1761–1810.
Wiwattanapatapee, R., Carreno-Gomez, B., Malik, N., & Duncan, R. (2000). Anionic PAMAM dendrimers rapidly cross adult rat intestine in vitro: A potential oral delivery system? Pharm Res, 17(8), 991–998.
Wu, P., Malkoch, M., Hunt, J. N., Vestberg, R., Kaltgrad, E., Finn, M. G., Fokin, V. V., Sharpless, K. B., & Hawker, C. J. (2005). Multivalent, bifunctional dendrimers prepared by click chemistry. Chem Commun (Camb) (46), 5775–5777.
Wu, P., Feldman, A. K., Nugent, A. K., Hawker, C. J., Scheel, A., Voit, B., Pyun, J., Frechet, J. M., Sharpless, K. B., & Fokin, V. V. (2004a). Efficiency and fidelity in a click-chemistry route to triazole dendrimers by the copper(I)-catalyzed ligation of azides and alkynes. Angew Chem Int Ed Engl, 43(30), 3928–3932.
Wu, X. Y., Huang, S. W., Zhang, J. T., & Zhuo, R. X. (2004b). Preparation and characterization of novel physically cross-linked hydrogels composed of poly(vinyl alcohol) and amine-terminated polyamidoamine dendrimer. Macromol Biosci, 4(2), 71–75.
Yoo, H., & Juliano, R. L. (2000). Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers. Nucleic Acids Res, 28(21), 4225–4231.
Yordanov, A. T., Lodder, A. L., Woller, E. K., Cloninger, M. J., Patronas, N., Milenic, D., & Brechbiel, M. W. (2002). Novel iodinated dendritic nanoparticles for computed tomography (CT) imaging. Nano Lett, 2(6), 595–599.
Zhuo, R. X., Du, B., & Lu, Z. R. (1999). In vitro release of 5-fluorouracil with cyclic core dendritic polymer. J Control Release, 57(3), 249–257.
Ziemer, L. S., Lee, W. M., Vinogradov, S. A., Sehgal, C., & Wilson, D. F. (2005). Oxygen distribution in murine tumors: Characterization using oxygen-dependent quenching of phosphorescence. J Appl Physiol, 98(4), 1503–1510.
Acknowledgments
Financial support was in part provided by the National Institute of General Medical Sciences National Research Service Award predoctoral fellowship to Kelly Kitchens (F31-GM67278) and a grant from the National Institutes of Health (RO1EB007470).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Kitchens, K.M., Ghandehari, H. (2009). PAMAM Dendrimers as Nanoscale Oral Drug Delivery Systems. In: de Villiers, M.M., Aramwit, P., Kwon, G.S. (eds) Nanotechnology in Drug Delivery. Biotechnology: Pharmaceutical Aspects, vol X. Springer, New York, NY. https://doi.org/10.1007/978-0-387-77668-2_14
Download citation
DOI: https://doi.org/10.1007/978-0-387-77668-2_14
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-77667-5
Online ISBN: 978-0-387-77668-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)